This video is sponsored by the Duke Clinical Medical Series.
* Wake-up Call
* Prevalence of DM in 1994
* DM Workforce
* DM and CAD: The Challenges
* BARI 7-year Results
* Revascularization Trends Before and After BARI
* Is Lower Blood Glucose Better?
* Natural History of Type 2 DM Typical Progression & Treatment
* Treatment Options: Where Are We Now?
* PROactive Effect of Add-on TZD Therapy on All-cause Mortality, Nonfatal MI, and Stroke
The host, Sunil Rao, MD, has indicated that he acts as a consultant for sanofi-aventis
and is a member of the speakers bureaus of the Medicines Company and the Cordis
The guest faculty, Michael Farkouh, MD, MsC, has indicated that he receives research/grant
support from GSK, and serves as a consultant for Novartis.